indazoles has been researched along with Experimental Hepatoma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, X; Li, Z; Zhao, W | 1 |
| Chai, Y; Chen, Y; Gao, J; Guo, H; Li, S; Liu, J; Lv, P; Pan, Y; Yan, X; Zhou, Y | 1 |
| Ding, H; Fan, PL; Gao, DM; Kong, LQ; Sun, HC; Tang, ZY; Wang, L; Wu, WZ; Xiong, YQ; Xu, HX; Zhang, JB; Zhang, W; Zhu, XD; Zhuang, PY | 1 |
| Fan, ST; Lam, CT; Lam, SP; Lau, CK; Ngai, P; Poon, RT; Tam, KH; Yang, ZF | 1 |
4 other study(ies) available for indazoles and Experimental Hepatoma
| Article | Year |
|---|---|
Combination therapy with local radiofrequency ablation and YC-1 inhibits the proliferation and metastasis of hepatocellular carcinoma through activating β-catenin signaling.
Topics: Animals; Apoptosis; beta Catenin; Catheter Ablation; Cell Line, Tumor; Cell Movement; Cell Proliferation; Combined Modality Therapy; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Indazoles; Liver Neoplasms, Experimental; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation | 2016 |
CT spectral imaging for monitoring the therapeutic efficacy of VEGF receptor kinase inhibitor AG-013736 in rabbit VX2 liver tumours.
Topics: Animals; Axitinib; Disease Models, Animal; Imidazoles; Indazoles; Liver; Liver Neoplasms, Experimental; Male; Protein Kinase Inhibitors; Rabbits; Receptors, Vascular Endothelial Growth Factor; Reproducibility of Results; Tomography, X-Ray Computed; Treatment Outcome | 2017 |
Antiangiogenic effects of pazopanib in xenograft hepatocellular carcinoma models: evaluation by quantitative contrast-enhanced ultrasonography.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Blood Vessels; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Image Enhancement; Indazoles; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Pyrimidines; Sulfonamides; Tumor Burden; Ultrasonography; Xenograft Model Antitumor Assays | 2011 |
Inhibition of Stat3 activity by YC-1 enhances chemo-sensitivity in hepatocellular carcinoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-X Protein; Carcinoma, Hepatocellular; Caspase 9; Cell Line, Tumor; Cisplatin; Cyclin D; Cyclins; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Indazoles; Inhibitor of Apoptosis Proteins; Liver Neoplasms; Liver Neoplasms, Experimental; Mice; Microtubule-Associated Proteins; Neoplasm Proteins; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Protein Processing, Post-Translational; STAT3 Transcription Factor; Survivin; Ubiquitination; Xenograft Model Antitumor Assays | 2007 |